Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1582969 | 0.90 | ALDH1A1 (0.91) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL1820762 | 0.90 | ALDH1A1 (1.00) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL11698375 | 0.89 | ALDH1A1 (0.67) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL11695704 | 0.89 | ALDH1A1 (0.67) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL4001371 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL8971393 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL8971703 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL8970657 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL8971430 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A | |
| SCHEMBL5463183 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP2C19CYP3A4CYP2C9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1135376-B1 | METHOD OF PRODUCING CYCLENE | SCHERING AG (DE) | 2003-09-17 | — | — | EP | claimed |
| US-6156890-A | Process for the production of cyclene | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-12-05 | — | — | US | claimed |
| EP-4313156-B1 | DISULFIDE-BASED PRODRUG COMPOUNDS | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2025-08-06 | — | — | EP | disclosed |
| US-20240207414-A1 | DISULFIDE-BASED PRODRUG COMPOUND | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4313156-A1 | DISULFIDE-BASED PRODRUG COMPOUNDS | Ludwig-Maximilians-Universität München (DE) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022200347-A1 | DISULFIDE-BASED PRODRUG COMPOUNDS | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2022-09-29 | — | — | WO | disclosed |
| US-10710968-B2 | Radiolabeled erlotinib analogs and uses thereof | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2020-07-14 | — | — | US | disclosed |
| EP-3176155-B1 | 1,2-BIS-(4,7-DIMETHYL-1,4,7-TRIAZACYCLONON-1-YL)-ETHANE AND INTERMEDIATE FOR THE SYNTHESIS OF SAME | CATEXEL LTD (GB) | 2019-09-25 | — | — | EP | disclosed |
| US-20190023664-A1 | RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2019-01-24 | — | — | US | disclosed |
| EP-3402536-A1 | RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED (IL) | 2018-11-21 | — | — | EP | disclosed |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2017-08-10 | — | — | US | disclosed |
| EP-0493601-B1 | LIQUID-CRYSTAL COPOLYMER, PRODUCTION THEREOF, DIENE COMPOUND USED IN SAID PRODUCTION, AND PRODUCTION OF SAID COMPOUND | IDEMITSU KOSAN CO (JP) | 1996-03-20 | — | — | EP | disclosed |
| US-5425897-A | Electrooptics | IDEMITSU KOSAN CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| US-5380915-A | Copolymers of polydimethylsiloxane with diene ethers | IDEMITSU KOSAN CO., LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| US-5281685-A | Polyether pendant groups, polysiloxane repeating units | IDEMITSU KOSAN CO., LTD. (JP) | 1994-01-25 | — | — | US | disclosed |
| EP-0493601-A1 | LIQUID-CRYSTAL COPOLYMER, PRODUCTION THEREOF, DIENE COMPOUND USED IN SAID PRODUCTION, AND PRODUCTION OF SAID COMPOUND | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-08 | — | — | EP | disclosed |
| US-5089614-A | Polysubstituted 2-morpholones | THE B. F. GOODRICH COMPANY (US) | 1992-02-18 | — | — | US | disclosed |
| US-4914232-A | FOR POLYMERS | THE B. F. GOODRICH COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| US-4639365-A | Gadolinium chelates as NMR contrast agents | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1987-01-27 | — | — | US | disclosed |
| US-4528370-A | Polysubstituted 2-morpholones | NOVEON IP HOLDINGS CORP., FORMERLY KNOWN AS PMD HOLDINGS CORP. | 1985-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10710968-B2 | Radiolabeled erlotinib analogs and uses thereof | EGFR, KRAS, ERBB4 | ALDH1A1 2112/4885CYP2C19 1733/4885CYP3A4 1588/4885 |
| US-20240207414-A1 | DISULFIDE-BASED PRODRUG COMPOUND | CBS, MSR1, P4HB | ALDH1A1 245/4885CYP2C19 1169/4885CYP3A4 2233/4885 |
| US-20170226317-A1 | POLARIZING PLATE PROTECTIVE FILM, POLARIZING PLATE, AND DISPLAY DEVICE | NBAS, SSB, BIRC5 | ALDH1A1 4014/4885CYP2C19 4263/4885CYP3A4 4760/4885 |
| US-20190023664-A1 | RADIOLABELED ERLOTINIB ANALOGS AND USES THEREOF | EGFR, KRAS, ERBB4 | ALDH1A1 2112/4885CYP2C19 1733/4885CYP3A4 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.